UNITY Biotechnology Announces Extension of Phase 2B Aspire Clinical Study Evaluating Ubx1325 in Dme
UNITY Biotechnology宣佈延長評估Dme中Ubx1325的2B期Aspire臨床研究
UNITY Biotechnology Announces Extension of Phase 2B Aspire Clinical Study Evaluating Ubx1325 in Dme
UNITY Biotechnology宣佈延長評估Dme中Ubx1325的2B期Aspire臨床研究
使用瀏覽器的分享功能,分享給你的好友吧